| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.024 | 0.9 |